These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 37305758)

  • 1. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
    Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
    Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
    Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
    J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
    Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
    Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease.
    Jackson A; Engen PA; Forsyth CB; Shaikh M; Naqib A; Wilber S; Frausto DM; Raeisi S; Green SJ; Bradaric BD; Persons AL; Voigt RM; Keshavarzian A
    Front Neurol; 2022; 13():882628. PubMed ID: 35665034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
    Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
    J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
    Sharma S; Awasthi A; Singh S
    Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis.
    Chen SJ; Lin CH
    J Biomed Sci; 2022 Jul; 29(1):54. PubMed ID: 35897024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human gut microbiota and Parkinson's disease.
    Pant A; Bisht KS; Aggarwal S; Maiti TK
    Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-
    Zhao Z; Li F; Ning J; Peng R; Shang J; Liu H; Shang M; Bao XQ; Zhang D
    Acta Pharm Sin B; 2021 Sep; 11(9):2859-2879. PubMed ID: 34589401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the gut be the missing piece in uncovering PD pathogenesis?
    Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
    Dong S; Sun M; He C; Cheng H
    Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.